Hair loss resumes within a specific timeframe following the withdrawal of finasteride treatment
the verdict
SUPPORTED
the evidence backs this
refutedsupported
the weight of evidence
1 source for · 0 against
AS REPORTEDno primary record reached; this is what the reporting says
Retrieved scientific literature indicates that hair loss and miniaturisation resume specifically after a timeframe of 12 months following the discontinuation of oral finasteride treatment.
Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a "drug dependency" and a post-finasteride "rebound effect"
## Abstract
Background: Analytical measures for the pharmacodynamics understanding of drug induced scalp hair responses are lacking.
Materials and methods: The present study measured in detail dynamics of hair productivity on two scalp test sites showing male pattern hair loss. The natural regression decay rate established after 2 years without treatment was followed by treatment with daily oral intake of 1 mg finasteride.
Results: While terminal hair (diameter ≥40 μm) were maintained "on-drug," within 30 months "off-drug" MPHL significantly worsened as 94% terminal hair miniaturised and became unproductive. Accordingly, the viable drug responding follicles were qualified as "finasteride dependent" unravelling a hereto unreported "rebound effect" after interruption of the drug intake. Interestingly, the transformation of terminal hair into miniaturised hair occurred only after 12 months without treatment, that is the time necessary to complete a clinically sign